Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yaglatimide hydrochloride in type 2 diabetes mellitus (phase II)
CTR20192351Phase 2Completed
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yaglatimide in type 2 diabetes mellitus (T2DM), sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started Nov 2019; status: completed.
02
Drugs
yaglatimide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192351.